LAMEA Neurovascular Catheters Market

LAMEA Neurovascular Catheters Market Size, Share & Industry Trends Analysis Report By Type, By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers), By Application, By Country and Growth Forecast, 2023 - 2029

Report Id: KBV-15139 Publication Date: April-2023 Number of Pages: 101
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Neurovascular Catheters Market would witness market growth of 10.6% CAGR during the forecast period (2023-2029).

The adaptability of neurovascular catheters is one of the features that play a role in determining their level of use. These catheters have been developed with the capability of being molded into a range of different shapes so that they can meet the needs of the person who will ultimately utilize them. Reputable businesses are currently working on the research and development of highly developed and individualized product solutions for neurovascular catheters in order to carry out minimally invasive surgery.

For instance, balloon catheters can be created in an array of lengths and sizes to carry out minimally invasive diagnostic and therapeutic treatments, such as enlarging arteries, removing obstructions, and delivering stents. These procedures include extending the lumen of blood vessels, removing obstructions, and delivering stents.

The neurovascular catheter market is experiencing swift technological progress, leading to the development of innovative products that offer improved features and benefits. As a result, the growing need for neurovascular catheters is expected to rise in the upcoming years.

Israel's aging population is in line with demographic trends. The 65+ age demographic has grown 18 times since 1950. Based on forecasts, the elderly demographic in Israel is anticipated to comprise 14% of the overall population, equivalent to 1.9 million individuals, by the year 2035. In the year of Israel's establishment, 1948, older people comprised a mere 4% of the population. In addition, there has been a steady 1% annual increase in life expectancy since 1995, which is expected to continue. The rising aging population in the area is anticipated to increase the need for neurovascular catheters, given that this group is more prone to neurological diseases like brain aneurysms, which utilize catheters for treatment, thereby surging the market growth in LAMEA.

The Brazil market dominated the LAMEA Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $80.2 million by 2029. The Argentina market is experiencing a CAGR of 11.2% during (2023 - 2029). Additionally, The UAE market would exhibit a CAGR of 10.3% during (2023 - 2029).

Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Neurovascular Catheters Market is Projected to reach USD 4.6 Billion by 2029, at a CAGR of 6.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Embolization Catheters
  • Access Catheters
  • Balloon Catheters
  • Microcatheters
  • Others

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Application

  • Brain Aneurysm
  • Embolic Stroke
  • Arteriovenous Malformations
  • Hydrolysate

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Stryker Corporation
  • Terumo Corporation
  • Integer Holdings Corporation
  • Penumbra, Inc.
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • Integra LifeSciences Corporation
  • Acandis GmbH
  • Spiegelberg GmbH & Co. KG
  • RAUMEDIC AG (REHAU Industries SE & Co. KG)
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo